HALKUFF DAWN

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 3% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 295%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
HALKUFF DAWN's trades of Xeris Biopharma Holdings Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-04 2026-06-04
PrS Proposed sale
51,958
255.79
US$4,463,411 		51,958 255.79 US$4,463,411
2025-08-13 2025-08-12
S Sale
22,238 +42.9%
293.62
US$4,485,336 		22,238 +42.9% 293.62 US$4,485,336
2025-08-12 2025-08-12
PrS Proposed sale
29,205
399.55
US$3,112,284 		29,205 399.55 US$3,112,284
2023-11-21 2023-11-20
B Purchase
5,410 +inf%
1.84
US$9,954 		5,410 +inf% 1.84 US$9,954